SEC Form 4 · accession 0001209191-15-024532
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W. Hesslein
Officer — SVP and General Counsel
Period of report
Mar 5, 2015
Accepted (ET)
Mar 10, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 5, 2015 | S | 4,635 | $47.24 | D | 68,125 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected to cover the tax liabilities of the reporting person in connection with the exercise of stock options. The reporting person exercised stock options on March 2, 2015 in order to participate in the tender offer commenced by Roche Holdings, Inc. on February 2, 2015.
- F2The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.20 to $47.27, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.